Healthcare is undergoing a fundamental transformation, shifting from reactive sick care to proactive health management, with consumers firmly in the driver’s seat. While the US market has seen the rise of consumer-centric healthcare champions like Hims/Hers, Headspace and Function Health, Europe’s market remains underserved. naturalX Health Ventures has announced a €100 million fund to accelerate this revolution in Europe, becoming the first specialised fund focused exclusively on the intersection of consumer and health in the European market.
The fund will focus primarily on Series-A investments while remaining flexible to participate in late Seed and Series-B rounds. Typical first investments range from €3-5 million, with up to €10 million available per company. naturalX can act as either lead investor or co-investor, targeting consumer health start-ups across Europe with selected investments in North America.